알테오젠

196170KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

231,000KRWMarket close of 10/20 (Tue)

Down -3.35%-8,000KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)240,000KRWUp +3.90%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
233,500
High
238,000
Low
226,000
Day range
Day range low 226,000 high 238,000, open 233,500, close 231,000, previous close 239,000
Volume
22×10K shares
51.1B KRW 0.66× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 213,500 to 559,000 won, 5% up from the low

5% of the way up from the lowest close in 1 year (252 sessions) · -58.7% from the high

Usual range

Nothing unusual in the 6 checked items

Free · no sign-inSource from 2021-05-17

Points to check

  • Daily moveusual range-3.35%-3.35%, 1.5× the usual (20-session average ±2.23%)
    That day -3.35% · usual ±2.23% · large-move threshold ±4.5%
  • Trading valueusual range0.7×51.1B KRW, 0.7× the 20-session average
    0.66× the 20-session average · check threshold 3×
  • Earningsusual range119.8B KRWOperating income over the last four quarters 119.8B KRWOperating income, 8 quarters

The other 3 are within the usual range

  • Recent filings0Last 14 days
  • Foreign & institutional+104.8B KRWusual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
올릭스Close over the last 20 sessions -12.2%Down -4.03%19.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
리가켐바이오Close over the last 20 sessions -15.4%Down -1.41%12.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW
바이오인프라Close over the last 20 sessions +123.3%Down -6.80%9.3B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 25 days
  • Next data 10/22 (Thu) after 08:50

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.